US EditionIVRO Continues Drive to Minimize Unnecessary Live Animal Testing
Summary by NewMediaWire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
IVRO Continues Drive to Minimize Unnecessary Live Animal Testing
PLACENTIA, CA - May 13, 2025 (NEWMEDIAWIRE) - Today, InVitro International (OTCQB: IVRO) reported first half FY '25 sales of $440,650, up 4.4% vs. the same period in FY '24. Net income of $49,239 declined from $65,345 (24.7%) for the same six months in FY '24, reflecting inflationary and OTCQB increased costs. CEO and Chairman, W. Richard Ulmer, enthused: "We believe IVRO's first half FY '25 indicates we may be entering a growth period for Non-…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
